Brief: Clinuvel Pharmaceuticals Expands Singapore Rd&I Centre To Pioneer Next-Generation Peptide Therapies
08/12/2025 01:01
Dec 8 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX: EXPANDS SINGAPORE RD&I CENTRE TO PIONEER NEXT-GENERATION PEPTIDE THERAPIES Further company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist